Cover Image

Emerging role of baricitinib in dermatology practice: All we need to know!

Baricitinib is a competitive inhibitor of the Janus Kinase family of non-receptor protein kinases, predominantly acting against JAK-1 and JAK-2 subtypes. By downregulating transcription of various pro-inflammatory cytokines, this drug has shown efficacy across various dermatoses. Approved for severe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sunil Dogra (Author), Shikha Shah (Author), Ayush Sharma (Author), Seema Chhabra (Author), Tarun Narang (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology
by: Sunil Dogra, et al.
Published: (2024)

Mycobacterium indicus pranii (MIP) vaccine: Pharmacology, indication, dosing schedules, administration, and side effects in clinical practice
by: Sunil Dogra, et al.
Published: (2023)

Application of Baricitinib in Dermatology
by: Zhang J, et al.
Published: (2022)

Emerging atypical and unusual presentations of dermatophytosis in India
by: Sunil Dogra, et al.
Published: (2017)

Inflammasome Related Mediators and Their Association with Disease Determinants in Chronic Plaque Psoriasis
by: Seema Chhabra, et al.
Published: (2021)

Dermatology At A Turning Point : Need to Preserve Medical Dermatology At A Turning Point : Need To Preserve Medical Dermatology
by: Dogra Sunil, et al.
Published: (2003)

Coronavirus is not the only corona we know in dermatology
by: Niharika Jha
Published: (2021)

Mohs Micrographic Surgery Comes to Dermatology Practice in India: Lessons Learnt Over 2 Years
by: Keshavamurthy Vinay, et al.
Published: (2024)

Rabies : What We Know and What We Need to Know
by: Sandhu TS
Published: (2004)

An analysis of dermatological quality-of-life scores in relation to psychiatric morbidity in psoriasis
by: Shubh Mohan Singh, et al.
Published: (2016)

Paediatric schistosomiasis: What we know and what we need to know.
by: Derick N M Osakunor, et al.
Published: (2018)

The discovery of musculus masseter pars coronidea: What we need to know?
by: P Charulata Sree, et al.
Published: (2023)

We all need to know about HIV cure research: a case report
by: Olubanke Davies, et al.
Published: (2015)

Towards open science: what we know and what we need to know
by: Álvaro Francisco Lopes de Sousa, et al.

All You Need Is Evidence: What We Know About Pneumonia in Children With Neuromuscular Diseases
by: Claudio Cherchi, et al.
Published: (2021)

Quality of life scales in pigmentary disorders
by: Shikha Shah, et al.
Published: (2023)

Vaccine refusal - what we need to know
by: Regina Célia de Menezes Succi
Published: (2018)

Vaccine refusal - what we need to know
by: Regina Célia de Menezes Succi
Published: (2018)

Microplastics- All we know till now and the way out
by: Utsav Raj, et al.
Published: (2018)

Dermatophytosis: Fighting the challenge: Conference proceedings and learning points. September 2-3, 2017, PGIMER, Chandigarh, India
by: Tarun Narang, et al.
Published: (2017)

Perception of pain and its control: all that we don't know yet
by: Mario Tiengo
Published: (2008)

Interpersonal violence against athletes <subtitle>What we know, what we need to know, and what we should do</subtitle>
by: Ralph E. Schmidt, et al.
Published: (2022)

IADVL multiple choice questions in dermatology, venereology and leprosy
by: Sunil Dogra
Published: (2023)

Indian Dermatology Online Journal (IDOJ) going the print way!
by: Sunil Dogra
Published: (2018)

COVID-19 and healthcare worker: What we need to know
by: Deepak Jakhar, et al.
Published: (2021)

Tourniquet application during anesthesia: "What we need to know?"
by: Kamal Kumar, et al.
Published: (2016)

International Trade and Investment and Food Systems: What We Know, What We Don't Know, and What We Don't Know We Don't Know
by: Ashley Schram, et al.
Published: (2021)

A critical appraisal of the ENLIST severity scale for erythema nodosum leprosum
by: Bhushan Kumar, et al.
Published: (2022)

A critical appraisal of the ENLIST severity scale for erythema nodosum leprosum.
by: Bhushan Kumar, et al.
Published: (2022)

Response to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines".
by: Bhushan Kumar, et al.
Published: (2020)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
by: Chuan-bin Sun, et al.
Published: (2020)

A Decade of College Student Hunger: What We Know and Where We Need to Go
by: Rebecca L. Hagedorn-Hatfield, et al.
Published: (2022)

Coronavirus disease 2019 (COVID-19): What we need to know
by: Mostafa Javanian, et al.
Published: (2020)

Measuring quality of care for all women and newborns: how do we know if we are doing it right? A review of facility assessment tools
by: Vanessa Brizuela, DrPH, et al.
Published: (2019)

Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?
by: Sanja Javor, et al.
Published: (2023)

Trends influencing researcher education and careers: What do we know, need to know and do in looking forward?
by: Montserrat Castelló, et al.
Published: (2015)

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
by: Gürkan Kaya, et al.
Published: (2018)

"We're on the ground, we know what needs to be done": Exploring the role of Aboriginal Health Workers in primary health care
by: Ragavi Jeyakumar, et al.
Published: (2023)

Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination"
by: Vinod Hanumanthu, MD, et al.
Published: (2022)

Odontogenic cutaneous sinus tracts: A clinician's dilemma
by: Muthu Sendhil Kumaran, et al.
Published: (2020)